Rhythm Pharmaceuticals
(NASDAQ) RYTM
Rhythm Pharmaceuticals Financials at a Glance
Market Cap
$5.89B
Revenue (TTM)
$189.76M
Net Income (TTM)
$196.54M
EPS (TTM)
$-3.11
P/E Ratio
-27.76
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$86.44
Volume
546,431.859
Open
$85.81
Price
$86.44
Volume
546,431.859
Open
$85.81
Previous Close
$86.29
Daily Range
$85.73 - $88.64
52-Week Range
$45.91 - $122.20
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$86.44
Volume
546,431.859
Open
$85.81
Previous Close
$86.29
Daily Range
$85.73 - $88.64
52-Week Range
$45.91 - $122.20
RYTM News
RYTM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rhythm Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
414
CEO
David P. Meeker, MD
Website
www.rhythmtx.comHeadquarters
Boston, MA 02116, US
RYTM Financials
Key Financial Metrics (TTM)
Gross Margin
90%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
-244%
Return on Capital
-51%
Return on Assets
-41%
Earnings Yield
-3.60%
Dividend Yield
0.00%
Payout Ratio
-0.01%
Stock Overview
Market Cap
$5.89B
Shares Outstanding
68.28M
Volume
546.43K
Short Interest
0.00%
Avg. Volume
837.01K
Financials (TTM)
Gross Profit
$170.26M
Operating Income
$192.02M
EBITDA
$174.12M
Operating Cash Flow
$115.67M
Capital Expenditure
$953.00K
Free Cash Flow
$116.63M
Cash & ST Invst.
$388.95M
Total Debt
$246.47M
Rhythm Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$57.25M
+36.9%
Gross Profit
$52.45M
+37.9%
Gross Margin
91.61%
N/A
Market Cap
$5.89B
N/A
Market Cap/Employee
$20.82M
N/A
Employees
283
N/A
Net Income
$47.51M
-9.7%
EBITDA
$42.65M
-13.6%
Quarterly Fundamentals
Net Cash
$142.48M
-55.0%
Accounts Receivable
$26.08M
+40.9%
Inventory
$25.75M
+37.4%
Long Term Debt
$238.53M
+5957.1%
Short Term Debt
$7.95M
N/A
Return on Assets
-40.84%
N/A
Return on Invested Capital
-51.17%
N/A
Free Cash Flow
$26.34M
-39.8%
Operating Cash Flow
$25.39M
-34.7%